The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition

Larissa C. Bergin (Jones Day) provides an overview of the often divergent rules adopted in different jurisdictions, including the EU, U.S., India, and China, exploring the impacts that biosimilar substitutability rules have on market entry and competition.

Read More (FDLI Members Only)
Become a FDLI Member